[ENZYME THERAPY OF PROGRESSIVE SYSTEMIC SCLEROSIS; PRELIMINARY EVALUATION OF A COMBINATION OF RHEUMAJECTA AD AND VASOBLASTIN].
D035843:Biomedical Research; D002374:Catalase; D002795:Choline O-Acetyltransferase; D004338:Drug Combinations; D004358:Drug Therapy; D057487:Enzyme Therapy; D004798:Enzymes; D006801:Humans; D045743:Scleroderma, Diffuse; D012595:Scleroderma, Systemic; D013430:Sulfate Adenylyltransferase; D013466:Sulfurtransferases
D004338:Drug Combinations; D004798:Enzymes; C023681:Rheumajecta; D002374:Catalase; D002795:Choline O-Acetyltransferase; D013430:Sulfate Adenylyltransferase; D013466:Sulfurtransferases
CLINICAL RESEARCH; DRUG THERAPY; ENZYMES; SCLERODERMA
TERAPIA ENZIM'ATICA EN ESCLEROSIS SIST'EMICA PROGRESIVA; EVALUACI'ON PRELIMINAR DE LA COMBINACI'ON DE RHEUMAJECTA Y VASOLASTINE.